A scholarly study of data from America’s largest pharmacy benefits manager concludes that Obamacare beneficiaries had lower drug spending than people in employer-based plans.
These are startling findings, and even contrary to earlier releases from Express Scripts itself. It does not seem consistent with emerging evidence that insurers are jacking up their Obamacare rates for 2016 because of higher than expected claims experience.
Read the entire entry at NCPA's Health Policy Blog.
Research and commentary from a former senior executive in the U.S. Department of Health & Human Services
No comments:
Post a Comment